Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02182
Species: Homo sapiens
Position : chr4:111553098-111553222
Year: 2016
Title: A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: atrial fibrillation
PMID:  27866707
MONDO: MONDO:0004981
Tissue: heart
Tissue Ontology ID: UBERON:0000948
Cell Source: hESC-derived cardiomyocytes
Cell Type: cardiac muscle cell
Cell Ontology ID: CL:0000746
Experiment Type: Disease-associated enhancer assay; TF binding assay; endogenous enhancer perturbation; Disease-variant functional analysis; In vivo functional validation
High Throughput Method: ENCODE and Roadmap epigenomic integration
Low Throughput Method: Dual-luciferase reporter assay; zebrafish enhancer reporter assay; CRISPR-Cas9 enhancer deletion; CRISPR allele editing; TFAP2A binding assay; qRT-PCR; CRISPR-Cas9 endogenous deletion/editing; In vivo phenotyping
About Target Gene
Target gene : PITX2
About TF
TF name : TFAP2A
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
TFAP2A Caspase Cascade in Apoptosis pid 57
TFAP2A Hs_Corticotropin-releasing_hormone_signaling_pathway_WP2355_90017 wikipathways 41
TFAP2A Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
TFAP2A Hs_Ectoderm_Differentiation_WP2858_89329 wikipathways 56
TFAP2A Hs_Hypothetical_Craniofacial_Development_Pathway_WP3655_88473 wikipathways 5
Enhancer Associated Network
Overlapping Enhancers (hg19) 4 found
Enhancer ID Position Tissue Cell Disease
E_02241 chr4:111552482-111553989 embryo NA atrial fibrillation
E_02192 chr4:111553081-111553310 heart cardiac muscle cell atrial fibrillation
E_02239 chr4:111553081-111553310 uterine cervix NA atrial fibrillation
E_02263 chr4:111553081-111553310 heart cardiac muscle cell atrial fibrillation
Expression of Target Genes for the Enhancer